Panel: CGT clinical trials at pace: What’s accelerating, what’s stuck and how Europe turns trials into treatments

A view on the latest clinical trials, innovations and trends coming out of Europe, US and further afield and what practical coordination would make cross-border trials, faster, simpler and more attractive?

From trial to treatment: How can we boost the flow of ATMPs through clinical development and into commercial use, and where are the real bottlenecks in Phase I and II?

Europe’s unfair advantage: What does Europe have that other regions do not, from investigator-initiated trials and Catapult infrastructure to talent inflows, including more recent trends from the US. How do we use this to our advantage?

How can we make it easier for clinical trials to be approved in Europe: Balancing national authority, ethics, and evidence, and still compete with China, Asia, and other fast-moving regions?

Patients at the heart: Engaging patients better at home and across borders, and where are the easy wins in last-mile trial delivery and access?